IL287813A - tricyclic compounds - Google Patents

tricyclic compounds

Info

Publication number
IL287813A
IL287813A IL287813A IL28781321A IL287813A IL 287813 A IL287813 A IL 287813A IL 287813 A IL287813 A IL 287813A IL 28781321 A IL28781321 A IL 28781321A IL 287813 A IL287813 A IL 287813A
Authority
IL
Israel
Prior art keywords
tricyclic compounds
tricyclic
compounds
Prior art date
Application number
IL287813A
Other languages
English (en)
Hebrew (he)
Original Assignee
Aligos Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aligos Therapeutics Inc filed Critical Aligos Therapeutics Inc
Publication of IL287813A publication Critical patent/IL287813A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL287813A 2019-05-30 2021-11-03 tricyclic compounds IL287813A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962854597P 2019-05-30 2019-05-30
PCT/US2020/034746 WO2020243199A1 (en) 2019-05-30 2020-05-27 Tricyclic compounds

Publications (1)

Publication Number Publication Date
IL287813A true IL287813A (en) 2022-01-01

Family

ID=73552666

Family Applications (1)

Application Number Title Priority Date Filing Date
IL287813A IL287813A (en) 2019-05-30 2021-11-03 tricyclic compounds

Country Status (19)

Country Link
US (1) US11136321B2 (cg-RX-API-DMAC7.html)
EP (1) EP3976618A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022534501A (cg-RX-API-DMAC7.html)
KR (1) KR20220016177A (cg-RX-API-DMAC7.html)
CN (1) CN113906029A (cg-RX-API-DMAC7.html)
AU (1) AU2020282707B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021023967A2 (cg-RX-API-DMAC7.html)
CA (1) CA3138938A1 (cg-RX-API-DMAC7.html)
CL (1) CL2021003139A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021017202A2 (cg-RX-API-DMAC7.html)
EA (1) EA202192760A1 (cg-RX-API-DMAC7.html)
IL (1) IL287813A (cg-RX-API-DMAC7.html)
MA (1) MA56058A (cg-RX-API-DMAC7.html)
MX (1) MX2021014458A (cg-RX-API-DMAC7.html)
PE (1) PE20220427A1 (cg-RX-API-DMAC7.html)
PH (1) PH12021552953A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202113214QA (cg-RX-API-DMAC7.html)
TW (1) TW202110845A (cg-RX-API-DMAC7.html)
WO (1) WO2020243199A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220000874A1 (en) * 2019-05-30 2022-01-06 Aligos Therapeutics, Inc. Tricyclic compounds
US12703701B2 (en) * 2019-12-10 2026-08-11 Shanghai Hansoh Biomedical Co., Ltd. Pyrazole-containing polycyclic derivative inhibitor, preparation method therefor and application thereof
GB202103704D0 (en) * 2021-03-17 2021-04-28 Pathios Therapeutics Ltd Compounds
WO2022115384A1 (en) * 2020-11-24 2022-06-02 Aligos Therapeutics, Inc. Tricyclic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0701273D0 (en) 2007-01-24 2007-02-28 Angeletti P Ist Richerche Bio New compounds
WO2008157273A1 (en) 2007-06-14 2008-12-24 Smithkline Beecham Corporation Chemical compounds
RU2016120763A (ru) * 2013-10-29 2017-12-05 Медивир Аб Ингибиторы респираторного синцитиального вируса
BR112018068177B1 (pt) 2016-03-09 2024-02-27 Emory University Composto, uso do composto e composição para eliminação do vírus da hepatite b com agentes antivirais
CN110066278B (zh) * 2017-06-01 2021-06-08 广东东阳光药业有限公司 稠合三环类化合物及其在药物中的应用

Also Published As

Publication number Publication date
BR112021023967A2 (pt) 2022-03-08
MA56058A (fr) 2022-04-06
TW202110845A (zh) 2021-03-16
CL2021003139A1 (es) 2022-09-23
EP3976618A1 (en) 2022-04-06
CN113906029A (zh) 2022-01-07
EP3976618A4 (en) 2023-01-04
JP2022534501A (ja) 2022-08-01
PH12021552953A1 (en) 2022-07-25
US20200407361A1 (en) 2020-12-31
CO2021017202A2 (es) 2022-01-17
MX2021014458A (es) 2022-01-06
WO2020243199A1 (en) 2020-12-03
EA202192760A1 (ru) 2022-03-05
PE20220427A1 (es) 2022-03-29
SG11202113214QA (en) 2021-12-30
CA3138938A1 (en) 2020-12-03
AU2020282707A1 (en) 2021-12-02
AU2020282707B2 (en) 2025-06-19
US11136321B2 (en) 2021-10-05
KR20220016177A (ko) 2022-02-08

Similar Documents

Publication Publication Date Title
ZA202207722B (en) Substituted tricyclic compounds
ZA202206253B (en) Substituted tricyclic compounds
GB201905721D0 (en) Compounds
GB201910305D0 (en) Compounds
GB201916915D0 (en) Compounds
GB201908536D0 (en) Compounds
ZA202100237B (en) Tricyclic compounds
GB201910304D0 (en) Compounds
GB201908095D0 (en) Carboxy-MIDA-boronate compounds
HUP1800332A1 (hu) Triciklusos vegyületek II
HK40069042A (en) Tricyclic compounds
GB201919205D0 (en) Compounds
GB201918761D0 (en) Compounds
GB201918424D0 (en) Compounds
GB201917891D0 (en) Compounds
GB201917895D0 (en) Compounds
GB201917893D0 (en) Compounds
GB201916847D0 (en) Compounds
GB201916597D0 (en) Compounds
GB201916595D0 (en) Compounds
GB201916142D0 (en) Compounds
GB201914208D0 (en) Compounds
GB201913633D0 (en) Compounds
GB201913541D0 (en) Compounds
GB201912850D0 (en) Compounds